Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.40 |
| ▸ | LMNA | P02545 | 7/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL21219115 | 0.98 | ALDH1A1 (0.54) | ALDH1A1SLC13A5KDM4ELMNATSHR | |
| SCHEMBL2872937 | 0.94 | ALDH1A1 (0.44) | ALDH1A1SLC13A5KDM4ELMNATSHR | |
| Citric Acid SCHEMBL25266373 | 0.89 | ALDH1A1 (0.52) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL317666 | 0.89 | ALDH1A1 (0.52) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL426934 | 0.88 | ALDH1A1 (0.65) | ALDH1A1SLC13A5KDM4ELMNATSHR | |
| SCHEMBL1219023 | 0.88 | NAAA (0.50) | ALDH1A1BLMHCAR2 | |
| SCHEMBL27684479 | 0.88 | NAAA (0.50) | ALDH1A1BLMHCAR2 | |
| Citric Acid SCHEMBL27893856 | 0.88 | NAAA (0.50) | ALDH1A1BLMHCAR2 | |
| SCHEMBL2872935 | 0.87 | ALDH1A1 (0.39) | ALDH1A1SLC13A5KDM4ELMNAMEN1 | |
| SCHEMBL9410612 | 0.86 | NAAA (0.53) | ALDH1A1TSHRBLMHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119265931-A | Environment-friendly starch slurry for sizing glass fiber yarns for high-density weaving and preparation method and application thereof | 江苏新瑞贝生物科技股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-118021727-A | Lenvatinib mesylate liposome, preparation method and preparation thereof | 浙江省肿瘤医院 | 2024-05-14 | — | — | CN | claimed |
| CN-113652140-B | Epoxy heavy-duty anticorrosive paint and application thereof | 肇庆中特能科技投资有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-110935286-B | Method for absorbing residual fumigant sulfuryl fluoride by using ionic liquid composite bio-based solvent | 浙江工业大学 | 2022-03-01 | — | — | CN | claimed |
| CN-111298667-B | Polymer-based blended film, and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2021-12-07 | — | — | CN | claimed |
| CN-113652140-A | Epoxy heavy-duty anticorrosive paint and application thereof | 肇庆中特能科技投资有限公司 | 2021-11-16 | — | — | CN | claimed |
| CN-111298667-A | Polymer-based blended film, and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2020-06-19 | — | — | CN | claimed |
| CN-110935286-A | Method for absorbing residual fumigant sulfuryl fluoride by using ionic liquid composite bio-based solvent | 浙江工业大学 | 2020-03-31 | — | — | CN | claimed |
| US-7833957-B2 | Removing solution | DAIKIN INDUSTRIES, LTD. (JP) | 2010-11-16 | — | — | US | claimed |
| US-20060138399-A1 | Removing solution | DAIKIN INDUSTRIES, LTD. (JP) | 2006-06-29 | — | — | US | claimed |
| US-6983801-B2 | Well treatment fluid compositions and methods for their use | BJ SERVICES COMPANY (US) | 2006-01-10 | — | — | US | claimed |
| CN-1678961-A | Removing solution | DAIKIN IND LTD (JP) | 2005-10-05 | — | — | CN | claimed |
| EP-1536291-A1 | REMOVING SOLUTION | Daikin Industries, Ltd. (JP) | 2005-06-01 | — | — | EP | claimed |
| US-20050016733-A1 | Well treatment fluid compositions and methods for their use | COMBINED SYSTEMS, INC. | 2005-01-27 | — | — | US | claimed |
| US-20020125012-A1 | Well treatment fluid compositions and methods for their use | BJ SERVICES COMPANY | 2002-09-12 | — | — | US | claimed |
| WO-2002055843-A1 | WELL TREATMENT FLUID COMPOSITIONS AND METHODS FOR THEIR USE | BJ SERVICES COMPANY (US) | 2002-07-18 | — | — | WO | claimed |
| EP-0614931-B1 | Process for the preparation of moulded articles from polyurethane foams | BAYER AG (DE) | 1997-05-28 | — | — | EP | claimed |
| US-5426124-A | With specific organic carboxylic acid blowing agents | BAYER AKTIENGESELLSCHAFT (DE) | 1995-06-20 | — | — | US | claimed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| US-4010253-A | Process of suppressing odors employing deodorants containing esters of citric acid | HENKEL & CIE G.M.B.H. (DT) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | ALDH1A1 737/4885SLC13A5 4597/4885KDM4E 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.